Homepage | CIDRAP CIDRAP provides information about its underwriters, supporting its mission to address infectious disease threats and promote public health
Osterholm Update - CIDRAP In the 200th episode of the Osterholm Update, Dr Osterholm and Chris Dall discuss recent changes to the childhood immunization schedule, the latest data on this year's influenza season, and an update on CIDRAP's Vaccine Integrity Project
COVID-19 - CIDRAP CIDRAP Op-Ed: The report that proves the point—ACIP, COVID vaccines, and predetermined conclusions My March 3 CIDRAP Op-Ed asked whether ACIP would follow the evidence or a political agenda The meeting didn’t happen But a leaked report answered my question
All News | CIDRAP Giving Tamiflu to 70% of nursing home residents within 2 days of an outbreak is linked to significantly fewer hospitalizations A growing number of parents are rejecting vitamin K shots for newborns, a choice that dramatically increases the risk of bleeding and strokes in infants In an
Vaccine Integrity Project - CIDRAP CIDRAP provides an initiative dedicated to safeguarding vaccine use in the U S, so that it remains grounded in the best available science
Roadmap | CIDRAP The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, with funding from the Bill Melinda Gates Foundation and The Rockefeller Foundation, created this research and development (R D) roadmap for broadly protective coronavirus vaccines (referred to as the Coronavirus Vaccines Roadmap [CVR]) to serve as a strategic planning tool to facilitate R D
The State of US Vaccine Policy — Feb 19, 2026 - CIDRAP Here we are—the second biweekly installment of The State of US Vaccine Policy, our ongoing series in partnership with CIDRAP (the Center for Infectious Disease Research and Policy at the University of Minnesota; read each installment here) The PDF version is here Two weeks ago, we were humbled by the conversations that followed our first issue
Public Health Alerts: Antibodies elicited by the 2025-2026 . . . - CIDRAP In spite of fears of immune evasion by a widely circulating H3N2 influenza variant called subclade K, a Public Health Alerts report published today shows that the current flu vaccine produces antibodies that efficiently recognize subclade K in almost 40% of people “Thus, the current seasonal
Календарь